Nu.Q Nucleosome is read across the whole body, not one organ.
Nu.Q Nucleosome
Emerging
1 reading · tracked as a trend, not scored against a reference range
Latest
21ng/mL
Trend
Baseline established. A second reading sets the direction.
What this is
A circulating-nucleosome cancer screen (Volition Nu.Q, distributed via IDEXX/Antech); flags systemic cancers such as lymphoma and haemangiosarcoma.
Why it’s experimental
A screening aid, not a diagnosis: a raised result must be confirmed with imaging/biopsy, and inflammation can raise nucleosomes.
Frontier markers are tracked for their direction of travel. They do not count toward the Healthspan Score, carry no optimal range, and are not diagnostic, so discuss any result with your veterinary surgeon.
